论文信息 - Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease - 字舞流文

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease

F. Spertini | A. Sleight | T. Martin | D. Courvoisier | E. Hachulla | C. Gabay | E. Feist | J. Rech | H. Schulze-Koops | J. Morel | B. Fautrel | T. Schaeverbeke | M. Hamidou | E. Schiffrin | P. Lamprecht | B. Hellmich | I. Kötter | J. Morel